Loading
Latest filing published 15 Sept 2026 for Humacyte, Inc., €4,848.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Keith Anthony Jones appears in our data through filings on Humacyte, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 17 August 2026 to 14 September 2026.
On the market, this insider has only ever bought: 3 purchases, €26k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €5,931. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 15 September 2026 with an open-market purchase (€4,848) in Humacyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations